Inhalation Drug Delivery, a podcast sponsored by 3M
The practice of using inhaled substances to treat medical conditions has been around for millennia. It?s only in the last hundred years, though, that advancements in technology have allowed inhalation drug delivery systems to become an important delivery method for pharmaceuticals used by millions of patients worldwide. In this episode, Richard Beesley from 3M Drug Delivery Systems gives us an overview of the factors that have shaped inhalation drug delivery and considers how we may best equip ourselves to manage change in the future.
The practice of using inhaled substances to treat medical conditions has been around for millennia. Only in the last hundred years, though, have advancements in technology have allowed inhalation drug delivery systems to become an important delivery method for pharmaceuticals used by millions of patients worldwide. In this interview, Richard Beesley from 3M Drug Delivery Systems provides an overview of the factors that have shaped inhalation drug delivery and considers how we may best equip ourselves to manage change in the future.
Find out about 3M’s Inhalation drug delivery technologies>>
Learn more about 3M’s manufacturing capabilities>>
Handling Sterile Potent, Powders Inside a Single Use, Disposable Aseptic Isolator with Martyn Ryder
April 28th 2021During this podcast we shall be discussing how sterile potent powders are becoming more common in the bio-pharmaceutical industry and the challenges around handling these powders in conventional aseptic containment systems. Review the overarching benefits of compliant. single use isolator systems when handling sterile products and how they mitigate the risk associated with potent product batch manufacture.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
